The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The agouti gene product inhibits lipolysis in human adipocytes via a Ca 2+ ‐dependent mechanism
Abstract
Overexpression of the murine agouti gene results in obesity. The human homologue of agouti is expressed primarily in human adipocytes, and we have shown recombinant agouti protein to increase adipocyte intracellular Ca 2+ ([Ca 2+ ] i ) and thereby stimulate lipogenesis. However, since recent data demonstrate that increasing adipocyte [Ca 2+ ] i may also inhibit lipolysis, we have investigated the role of agouti‐induced [Ca 2+ ] i increases in regulating lipolysis in human adipocytes. Short‐term (1 h) exposure to recombinant agouti (100 nM) protein had no effect on basal lipolysis, although longer term treatment (24 h) caused a 60% decrease in basal lipolysis ( P <0.0001). Short‐term agouti treatment totally inhibited ACTH‐induced lipolysis ( P <0.05). Since melanocortin receptors (MCR) are involved in some actions of agouti, we next determined whether agouti's antilipolytic effect is exerted through competitive antagonism of the ACTH receptor (MCR‐2). Forskolin (1 µM), an adenylate cyclase activator, induced a 48% increase in lipolysis in human adipocytes ( P <0.05); this effect was reversed by 100 nM agouti ( P <005), demonstrating that the antilipolytic effect of agouti is distal to the ACTH receptor. To determine the role of [Ca 2+ ] i in the antilipolytic effect of agouti, human adipocytes were treated with KCl or arginine vasopressin to stimulate voltage‐ and receptor‐stimulated Ca 2+ influx, respectively. Both agents caused inhibition of forskolin‐induced lipolysis ( P <0.005). Furthermore, agouti's antilipolytic effect was also blocked by the Ca 2+ channel blocker nitrendipine. These data demonstrate that agouti exerts a potent antilipolytic effect in human adipocytes viaaCa 2+ ‐dependent mechanism. This effect, combined with agouti‐induced lipogenesis, represents a coordinate control of adipocyte lipid metabolism that may contribute to an agouti‐induced obesity syndrome.— Xue, B., Moustaid‐Moussa, N., Wilkison, W. O., Zemel, M. B. The agouti gene product inhibits lipolysis in human adipocytes via a Ca 2+ ‐dependent mechanism. FASEB J. 12, 1391–1396 (1998)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 1×
“It has recently been demonstrated that homologous recombinant knockout mice of the MCR4 gene became obese and insulin resistant with a time course similar to that found in yellow (A) mice (30).”
Background
Cited by
Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
Yaswen, L., Diehl, N., Brennan, M. B., & Hochgeschwender, U. (1999) · Nature Medicine · doi:10.1038/12506 · Cited by 1,012
Regulation of adiposity by dietary calcium
Zemel, M. B., Shi, H., Greer, B., Dirienzo, D., & Zemel, P. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1132 · Cited by 968
Self-citationChen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X.-M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., et al. (2000) · Nature Genetics · doi:10.1038/79254 · Cited by 894
Calcium and Dairy Acceleration of Weight and Fat Loss during Energy Restriction in Obese Adults
Zemel, M. B., Thompson, W., Milstead, A., Morris, K., & Campbell, P. (2004) · Obesity Research · doi:10.1038/oby.2004.67 · Cited by 601
Self-citationMolecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis
Holm, C., Østerlund, T., Laurell, H., & Contreras, J. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.365 · Cited by 564
Azadbakht, L., Mirmiran, P., Esmaillzadeh, A., Azizi, T., & Azizi, F. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2823 · Cited by 536
RAVUSSIN, E., & SMITH, S. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04292.x · Cited by 462
Ha, E., & Zemel, M. B. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00030-5 · Cited by 455
Self-citationHeilbronn, L., Smith, S. R., & Ravussin, E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802853 · Cited by 412
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Azadbakht, L., Mirmiran, P., Esmaillzadeh, A., & Azizi, F. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.3.523 · Cited by 399
Role of calcium and dairy products in energy partitioning and weight management
Zemel, M. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.907s · Cited by 396
Self-citationRegulation of Adiposity and Obesity Risk By Dietary Calcium: Mechanisms and Implications
Zemel, M. B. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719212 · Cited by 389
Self-citationShi, H., DiRienzo, D., & Zemel, M. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0584fje · Cited by 297
Self-citationMcCarty, M. F., & Thomas, C. A. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00227-5 · Cited by 289
The Role of Dairy Foods in Weight Management
Zemel, M. B. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719502 · Cited by 272
Self-citationLaity, J. H., & Andrews, G. K. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.019 · Cited by 267
Sengenès, C., Bouloumié, A., Hauner, H., Berlan, M., Busse, R., Lafontan, M., & Galitzky, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303713200 · Cited by 267
Magnesium, inflammation, and obesity in chronic disease: Nutrition Reviews©, Vol. 68, No. 6
Nielsen, F. H. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00293.x · Cited by 266
1α,25‐Dihydroxyvitamin D 3 modulates human adipocyte metabolism via nongenomic action
Shi, H., Norman, A. W., Okamura, W. H., Sen, A., & Zemel, M. B. (2001) · The FASEB Journal · doi:10.1096/fj.01-0584fje · Cited by 253
Self-citationDemographically-based evaluation of genomic regions under selection in domestic dogs
Freedman, A. H., Schweizer, R. M., Ortega-Del Vecchyo, D., Han, E., Davis, B. W., Gronau, I., Silva, P. M., Galaverni, M., Fan, Z., Marx, P., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005851 · Cited by 104
Goossens, G. H., Blaak, E. E., Saris, W. H. M., & van Baak, M. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032053 · Cited by 84
Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
El Bekay, R., Coín‐Aragüez, L., Fernández‐García, D., Oliva‐Olivera, W., Bernal‐López, R., Clemente‐Postigo, M., Delgado‐Lista, J., Diaz‐Ruiz, A., Guzman‐Ruiz, R., Vázquez‐Martínez, R., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13481 · Cited by 78
Melanocortin agonists stimulate lipolysis in human adipose tissue explants but not in adipocytes
Møller, C. L., Pedersen, S. B., Richelsen, B., Conde-Frieboes, K. W., Raun, K., Grove, K. L., & Wulff, B. S. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1539-4 · Cited by 22
Plasma leptin suppression by arginine vasopressin in normal women and men
Rubin, R. T., Rhodes, M. E., & Czambel, R. K. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02369-x · Cited by 6
Metadata
- Authors
- Xue, B., Moustaid‐Moussa, N., Wilkison, W. O., & Zemel, M. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1998-10
- Volume
- 12
- Issue
- 13
- Pages
- 1391-1396
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2121582872
- Cited by
- 172
- References
- 1
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.